Deferasirox Tablet, For Suspension
Product Images NDC 69539-022

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Deferasirox (NDC 69539-022). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Msn Laboratories Private Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

125mg 100s Blister Carton

This appears to be the product information for Deferasirox tablets which are used for oral suspension. The tablets come in different strengths, including 80mg and 108mg per tablet.*

FDA Label Image

125mg 10s Blister Foil

This text appears to be a list of various products and their descriptions, including Deferasirox Tablet and Deferasirox Tablet for Oral Suspension. The products have different dosages and are intended for institutional use only. The manufacturer of some of the products is listed as SN Laboratories Private Limited and they were made in India. However, due to the incomplete nature of the text and inconsistencies in the formatting, it may not be possible to determine the exact details of the products listed.*

FDA Label Image

250mg 100s Blister Carton

These are Deferasirox tablets, each containing 5 mg, in a package of 100 (10 x 10 unit-dose) tablets. They are for oral suspension and should not be chewed or swallowed whole; rather they must be dispersed in water, orange or apple juice prior to ingestion. The medication guide must be delivered by the pharmacist to each patient. The manufacturer is MSN Laboratories Private Limited located in Telangana- 509 228, INDIA, and the medication is distributed by MSN Pharmaceuticals Inc. from Piscataway, NJ 08854-3714. The tablets should be stored at 20°C to 25°C (68°F to 77°F) with permitted excursions to 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature] and protected from moisture. For institutional use only.*

FDA Label Image

250mg 10s Blister Foil

The text appears to be a packaging label of Deferasirox tablets and oral suspension for institutional use. However, due to the extensive use of characters such as |, & and other non-readable characters, the text is difficult to comprehend clearly.*

FDA Label Image

500mg 100s Blister Carton Label

This is a description of a package containing 100 Deferasirox Tablets for Oral Suspension. The package has 10 x 10 unit-dose tablets with E milligrams per tablet. The text includes a warning not to chew or swallow whole tablets and instructs the pharmacist to dispense medication to the patient. The package is for institutional use only.*

FDA Label Image

500mg 10s Blister Foil

FDA Label Image

125mg-1000s (Deferasirox 125mg 1000s Count)

Deferasirox Tablets are meant to be orally taken, with the dosage instructions mentioned in the prescribing information. The tablets must be stored at a temperature between 20°C to 25°C and can also be kept between 15°C to 30°C. The medication must be kept in a dry place and away from the reach of children. These tablets are manufactured by MSN Laboratories Private Limited based in Telangana, India, and distributed by MSN Pharmaceuticals Inc. located in Piscataway, NJ. These tablets come with a medication guide, which pharmacists need to dispense to each patient. The text also includes other details such as manufacturing date, Rx Only NDC code, and tablet instructions.*

FDA Label Image

125mg-30s (Deferasirox 125mg 30s Count)

Deferasirox Tablets are intended for oral suspension, with a dosage described in the prescribing information. They should be stored at temperatures between 20°C and 25°C and protected from moisture. Excursions are permitted to 15°C to 30°C. This medication must be kept out of the reach of children. The tablets are manufactured by MSN Laboratories Private Limited in Telangana, India, and distributed by MSN Pharmaceuticals Inc. in Piscataway, NJ. The tablets have a strength of 23mg and should not be chewed or swallowed whole; they must be dispersed in water, orange or apple juice before ingestion. Pharmacists should dispense the medication guide to each patient.*

FDA Label Image

125mg-90s (Deferasirox 125mg 90s Count)

FDA Label Image

250mg-1000s (Deferasirox 250mg 1000s Count)

This is a description for Deferasirox tablets for Oral Suspension. The dosage information is unavailable, it is necessary to check prescribing information. The tablets should be stored at a temperature between 20°C to 25°C and protected from moisture. The tablets should be dispersed in water, orange, or apple juice before ingestion and should not be chewed or swallowed whole. The medication should be kept away from the reach of children. The package contains 1000 tablets. The product is manufactured by MSN Laboratories Private Limited and distributed by MSN Pharmaceuticals Inc. The pharmacist should provide the patients with the medication guide.*

FDA Label Image

250mg-30s (Deferasirox 250mg 30s Count)

Deferasirox Tablets are for oral suspension and require dispersion in water, orange or apple juice prior to ingestion. They should be stored at 20°C to 25°C but excursions are permitted to 15°C t0 30°C. The medication is manufactured by MSN Laboratories Private Limited in India and distributed by MSN Pharmaceuticals Inc. in Piscataway, NJ. The packaging includes a medication guide for each patient and cautionary messages to keep medications away from children. Dosage information is available in the prescribing information with a National Drug Code of 69539-022.*

FDA Label Image

250mg-90s (Deferasirox 250mg 90s Count)

Deferasirox Tablets are available in a container of 90 tablets, and should be stored at 20°C to 25°C, with humidity control to prevent moisture. It is recommended to keep this medication out of the reach of children, and each patient should receive a Medication Guide. The tablets must be dispersed in water, orange or apple juice prior to ingestion and should not be chewed or swallowed whole. For additional information on dosage, please refer to the prescribing information. The tablets are manufactured by MSN Laboratories Private Limited, located in Telangana, India, and distributed by MSN Pharmaceuticals Inc. located in Piscataway, NJ, USA.*

FDA Label Image

500mg-30s (Deferasirox 500mg 30s Count)

This appears to be a description of a medication called Deferasirox Tablets. The recommended dosage is not provided and the text suggests referring to the prescribing information. The tablets must be dispersed in water or juice before ingestion, and not chewed or swallowed whole. The medication should be kept out of reach of children and protected from moisture. It is manufactured by MSN Laboratories Private Limited in India and distributed by VSNPharmaceuticas in Piscataway, NJ. The text includes a variety of product codes, but no information on the indications or medical conditions it is used to treat.*

FDA Label Image

500mg-500s (Deferasirox 500mg 500s Count)

This text contains information about dosage and storage for a medication, including the NDC number and manufacturer contact information. It advises to keep the medication away from children and protect it from moisture. The tablets should be dispersed in water or juice prior to ingestion and the accompanying medication guide should be dispensed by the pharmacist to each patient. Available in a pack of 500 tablets.*

FDA Label Image

500mg-90s (Deferasirox 500mg 90s Count)

This is a medication information sheet for Deferasirox Tablets for Oral Suspension®. The dosage information is not available and the medication must be stored at a temperature between 15°C to 30°C. The medication must be protected from moisture and kept out of the reach of children. The medication is manufactured by MSN Laboratories Private Limited in India, and distributed by MSN Pharmaceuticals Inc. in Piscataway, NJ. The tablets are not to be chewed or swallowed whole and must be dispersed in water, orange, or apple juice prior to ingestion. There is a medication guide that should be dispensed to each patient.*

FDA Label Image

Fig-01 (Deferasirox Figure 1)

FDA Label Image

Str (Deferasirox Structure)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.